The comparative efficacy and safety of sugammadex and neostigmine in reversing neuromuscular blockade in adults. A Cochrane systematic review with meta-analysis and trial sequential analysis

被引:102
|
作者
Hristovska, A. -M. [1 ]
Duch, P. [2 ]
Allingstrup, M. [1 ]
Afshari, A. [1 ]
机构
[1] Copenhagen Univ Hosp, Juliane Marie Ctr, Dept Pediat & Obstet Anaesthesia, Copenhagen, Denmark
[2] Copenhagen Univ Hosp, Juliane Marie Ctr, Dept Neuroanaesthesia, Copenhagen, Denmark
关键词
adverse events; neostigmine; recovery time; sugammadex; systematic review; LAPAROSCOPIC SURGERY; CONVENTIONAL REVERSAL; INTRAOCULAR-PRESSURE; POSTOPERATIVE NAUSEA; VS; NEOSTIGMINE; ATROPINE; ANESTHESIA; MANAGEMENT; SYMPTOMS; RECOVERY;
D O I
10.1111/anae.14160
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
We compared the efficacy and safety of sugammadex and neostigmine in reversing neuromuscular blockade in adults. Our outcomes were: recovery time from second twitch to train-of-four ratio >0.9; recovery time from post-tetanic count 1-5 to train-of-four ratio >0.9; and risk of composite adverse and serious adverse events. We searched for randomised clinical trials irrespective of publication status and date, blinding status, outcomes reported or language. We included 41 studies with 4206 participants. Time to reversal of neuromuscular blockade from second twitch to a train-of-four ratio >0.9 was 2.0min with sugammadex 2mg.kg(-1) and 12.9min with neostigmine 0.05mg.kg(-1), with a mean difference (MD) (95%CI)) of 10.2 (8.5-12.0) (I-2=84%, 10 studies, n=835, Grades of Recommendation, Assessment, Development and Evaluation (GRADE): moderate quality). Time to reversal of neuromuscular blockade from a post-tetanic count of 1-5 to a train-of-four ratio >0.9 was 2.9min with sugammadex 4mg.kg(-1) and 48.8min with neostigmine 0.07mg.kg(-1), with a MD (95%CI) of 45.8 (39.4-52.2) (I-2=0%, 2 studies, n=114, GRADE: low quality). There were significantly fewer composite adverse events in the sugammadex group compared with neostigmine, with a risk ratio (95%CI) of 0.60 (0.49-0.74) (I-2=40%, 28 studies, n=2298, number needed to treat (NNT): 8, GRADE: moderate quality). Specifically, the risk of bradycardia (RR (95%CI) 0.16 (0.07-0.34), n=1218, NNT: 14, GRADE: moderate quality), postoperative nausea and vomiting (RR (95%CI) 0.52 (0.28-0.97), n=389, NNT: 16, GRADE: low quality) and overall signs of postoperative residual paralysis (RR (95%CI) 0.40 (0.28-0.57), n=1474, NNT: 13, GRADE: moderate quality) were all reduced. There was no significant difference regarding the risk of serious adverse events (RR 0.54, 95%CI 0.13-2.25, I-2=0%, n=959, GRADE: low quality). Sugammadex reverses neuromuscular blockade more rapidly than neostigmine and is associated with fewer adverse events.
引用
收藏
页码:631 / 641
页数:11
相关论文
共 50 条
  • [1] Efficacy and safety of Sugammadex versus Neostigmine in reversing neuromuscular blockade in adults: a Cochrane systematic review with trial sequential analysis
    Hristovska, Ana-Marija
    Duch, Patricia
    Allingstrup, Mikkel
    Afshari, Arash
    [J]. ACTA ANAESTHESIOLOGICA SCANDINAVICA, 2017, 61 (08) : 967 - 968
  • [2] Efficacy and safety of sugammadex versus neostigmine in reversing neuromuscular blockade in adults
    Hristovska, Ana-Marija
    Duch, Patricia
    Allingstrup, Mikkel
    Afshari, Arash
    [J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2017, (08):
  • [3] Efficacy and safety of sugammadex sodium in reversing rocuronium-induced neuromuscular blockade in children: An updated systematic review and meta-analysis
    Zhou, Sheng
    Hu, Haiying
    Ru, Jianfen
    [J]. HELIYON, 2023, 9 (08)
  • [4] Efficacy and safety of sugammadex compared to neostigmine for reversal of neuromuscular blockade: a meta-analysis of randomized controlled trials
    Carron, Michele
    Zarantonello, Francesco
    Tellaroli, Paola
    Ori, Carlo
    [J]. JOURNAL OF CLINICAL ANESTHESIA, 2016, 35 : 1 - 12
  • [5] Sugammadex versus Neostigmine for Reversal of Neuromuscular Blockade in Adults and Children: A Systematic Review and Meta-analysis of Randomized Controlled Trials
    Chhabra, Ridhi
    Gupta, Rachna
    Gupta, Lalit K.
    [J]. CURRENT DRUG SAFETY, 2024, 19 (01) : 33 - 43
  • [6] Postoperative pulmonary complications after sugammadex reversal of neuromuscular blockade: a systematic review and meta-analysis with trial sequential analysis
    Hong-Mei Liu
    Hong Yu
    Yi-Ding Zuo
    Peng Liang
    [J]. BMC Anesthesiology, 23
  • [7] Postoperative pulmonary complications after sugammadex reversal of neuromuscular blockade: a systematic review and meta-analysis with trial sequential analysis
    Liu, Hong-Mei
    Yu, Hong
    Zuo, Yi-Ding
    Liang, Peng
    [J]. BMC ANESTHESIOLOGY, 2023, 23 (01)
  • [8] THE EFFICACY AND SAFETY OF SUGAMMADEX ON REVERSING POSTOPERATIVE RESIDUAL NEUROMUSCULAR BLOCKADE IN PEDIATRIC PATIENTS: A SYSTEMATIC REVIEW AND QUALITATIVE ANALYSIS
    Wang, R.
    Liu, G.
    Fan, L.
    Xue, J.
    Wang, T.
    [J]. ANESTHESIA AND ANALGESIA, 2016, 123 : 350 - 350
  • [9] Efficacy and safety of neostigmine for neuromuscular blockade reversal in patients under general anesthesia: a systematic review and meta-analysis
    Ji, Wentao
    Zhang, Xiaoting
    Liu, Jia
    Sun, Guolin
    Wang, Xiandong
    Bo, Lulong
    Deng, Xiaoming
    [J]. ANNALS OF TRANSLATIONAL MEDICINE, 2021, 9 (22)
  • [10] Efficacy and safety of sugammadex for neuromuscular blockade reversal in pediatric patients: an updated meta-analysis of randomized controlled trials with trial sequential analysis
    Lang, Bingchen
    Han, Lu
    Zeng, Linan
    Zhang, Qianqian
    Chen, Shouming
    Huang, Liang
    Jia, Zhijun
    Yu, Qin
    Zhang, Lingli
    [J]. BMC PEDIATRICS, 2022, 22 (01)